ValidCare
Validcare is a US-based contract research organization (CRO) that provides cloud-based, regulatory-compliant clinical trial infrastructure and end-to-end operational services. The company offers a Platform-as-a-Service (PaaS) for site-based, hybrid and decentralized clinical studies, combining e-source data capture, trial management functionality, automated patient engagement, and real‑world evidence support to help sponsors plan and execute trials on time and on budget.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Cloud-based clinical study platform (21 CFR Part 11 compliant)
A configurable clinical study platform supporting EDC, CTMS, eConsent, ePRO/eCOA, investigator portal and mobile patient apps for hybrid and decentralized trials.
SmartSource Platform
A comprehensive clinical trial platform that captures direct source data from investigators and patients to eliminate transcription, reduce queries, and accelerate database lock.
Cloud-based clinical study platform (21 CFR Part 11 compliant)
A configurable clinical study platform supporting EDC, CTMS, eConsent, ePRO/eCOA, investigator portal and mobile patient apps for hybrid and decentralized trials.
SmartSource Platform
A comprehensive clinical trial platform that captures direct source data from investigators and patients to eliminate transcription, reduce queries, and accelerate database lock.
Services
Protocol development, site/investigator selection, patient recruitment, monitoring, data management and regulatory support for interventional and non-interventional studies.
Provision of a configurable, private-label clinical study platform that supports site-based, hybrid and decentralized studies with investigator and patient-facing apps.
Centralized data cleaning, database lock support and statistical analysis to accelerate availability of the final dataset.
Design and operational execution for RWE and observational studies including regulatory intelligence integration.
Private-labeling of the clinical study platform for partners and institutions.
Protocol development, site/investigator selection, patient recruitment, monitoring, data management and regulatory support for interventional and non-interventional studies.
Provision of a configurable, private-label clinical study platform that supports site-based, hybrid and decentralized studies with investigator and patient-facing apps.
Centralized data cleaning, database lock support and statistical analysis to accelerate availability of the final dataset.
Design and operational execution for RWE and observational studies including regulatory intelligence integration.
Private-labeling of the clinical study platform for partners and institutions.
Expertise Areas
- Contract research organization (CRO) services
- Decentralized and hybrid clinical trials
- Clinical protocol development
- Clinical data management and eSource
Key Technologies
- Cloud-based clinical trial platform
- 21 CFR Part 11 compliance
- Electronic data capture (EDC)
- Clinical Trial Management System (CTMS)
News & Updates
Validcare selected as CRO for a randomized, double-blind, placebo-controlled Phase 2a DMT study; Validcare also agreed to an equity investment in the study sponsor subsidiary.
Validcare contracted to run a Growth Monitoring Study of healthy term infants to support U.S. market authorization; includes smart data capture and nationwide site network.
FIU selected Validcare's Platform-as-a-Service to power hybrid and decentralized clinical trials across the university.
Validcare to provide protocol development, e-source data collection, data management and statistical analysis for an ophthalmic proof-of-concept study.
Industry insights on investment challenges facing early-stage biotech (listed on Validcare news index).
Discussion of organizational and process topics required to successfully adopt decentralized clinical trial technologies.
Validcare selected as CRO for a randomized, double-blind, placebo-controlled Phase 2a DMT study; Validcare also agreed to an equity investment in the study sponsor subsidiary.
Validcare contracted to run a Growth Monitoring Study of healthy term infants to support U.S. market authorization; includes smart data capture and nationwide site network.
FIU selected Validcare's Platform-as-a-Service to power hybrid and decentralized clinical trials across the university.
Validcare to provide protocol development, e-source data collection, data management and statistical analysis for an ophthalmic proof-of-concept study.
Industry insights on investment challenges facing early-stage biotech (listed on Validcare news index).
Discussion of organizational and process topics required to successfully adopt decentralized clinical trial technologies.